Gluetacs was honored with 2024 Shanghai high-tech enterprises and 2024 Special Fund for Promoting the Integration of Industry and Education in the Lingang Special Area of the China (Shanghai) Pilot Free Trade Zone

ON：2024-12-24 TAGS：GLUETACS THERAPEUTICS

Recently, in accordance with the regulations of the relevant departments, the list of proposed high-tech enterprises for the third batch in Shanghai in 2024 has been made public after rigorous review. Gluetacs Therapeutics proudly made the list, successfully joining the ranks of high-tech enterprises. This achievement highlights our company’s outstanding strength and remarkable accomplishments in the field of technological innovation. It also signifies that with policy support, our company will steadily progress on the path of high-tech development, continuing to contribute innovative power to the growth of the pharmaceutical industry.

Recently, the Lin-gang Special Area Administration announced the list of projects to be supported by the “2024 Special Fund for Promoting the Integration of Industry and Education in the Lingang Special Area of the China (Shanghai) Pilot Free Trade Zone.” Gluetacs Therapeutics is honored to be on the list, and the thematic work, having passed the review, will receive special fund subsidies. The initiation of this project fully reflects the high recognition of the Lingang Special Area towards Gluetacs’ efforts in promoting the integration of industry and education, fostering talent development, and advancing industrial growth.